Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of August 2026

  1. Viridian Therapeutics Inc.

    World Rank (Aug-2026)
    5,601
    Market Cap (Aug-2026)
    2.501 Billion USD
    World Rank (Jan-05-2024)
    7,887
    Market Cap (Jan-05-2024)
    1.157 Billion USD
    World Rank (Jul-30-2023)
    10,091
    Market Cap (Jul-30-2023)
    0.775 Billion USD
    World Rank (Dec-25-2022)
    7,533
    Market Cap (Dec-25-2022)
    1.200 Billion USD
    World Rank (Jan-07-2022)
    14,511
    Market Cap (Jan-07-2022)
    0.43 Billion USD
    Annual Revenue in USD
    71 Million USD
    Annual Operating Income in USD
    -363 Million USD
    Annual Net Income in USD
    -343 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  2. UFP Technologies

    World Rank (Aug-2026)
    5,610
    Market Cap (Aug-2026)
    2.492 Billion USD
    World Rank (Jan-05-2024)
    7,568
    Market Cap (Jan-05-2024)
    1.243 Billion USD
    World Rank (Jul-30-2023)
    7,001
    Market Cap (Jul-30-2023)
    1.456 Billion USD
    World Rank (Dec-25-2022)
    9,077
    Market Cap (Dec-25-2022)
    0.876 Billion USD
    World Rank (Jan-07-2022)
    12,895
    Market Cap (Jan-07-2022)
    0.55 Billion USD
    Annual Revenue in USD
    603 Million USD
    Annual Operating Income in USD
    92 Million USD
    Annual Net Income in USD
    68 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    UFP Technologies is primarily a medical designer and manufacturer company of custom devices, sub assemblies, components and packaging utilizing highly specialized foams, films and plastics. It is diversified in providing highly engineered products and components to customers in the aerospace, defense, automotive, consumer, electronics and industrial markets. The headquarters is in USA.
  3. BioCryst Pharmaceuticals

    World Rank (Aug-2026)
    5,615
    Market Cap (Aug-2026)
    2.489 Billion USD
    World Rank (Jan-05-2024)
    7,310
    Market Cap (Jan-05-2024)
    1.323 Billion USD
    World Rank (Jul-30-2023)
    7,021
    Market Cap (Jul-30-2023)
    1.451 Billion USD
    World Rank (Dec-25-2022)
    5,228
    Market Cap (Dec-25-2022)
    2.135 Billion USD
    World Rank (Jan-07-2022)
    6,134
    Market Cap (Jan-07-2022)
    2.08 Billion USD
    Annual Revenue in USD
    875 Million USD
    Annual Operating Income in USD
    341 Million USD
    Annual Net Income in USD
    264 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    BioCryst Pharmaceuticals is a Biotechnology company designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP). The company annual revenue is 49 million USD and 140 employees as on 2019. The headquarters is in USA.
  4. Nektar Therapeutics

    World Rank (Aug-2026)
    5,639
    Market Cap (Aug-2026)
    2.467 Billion USD
    World Rank (Jan-05-2024)
    21,027
    Market Cap (Jan-05-2024)
    0.108 Billion USD
    World Rank (Jul-30-2023)
    21,502
    Market Cap (Jul-30-2023)
    0.103 Billion USD
    World Rank (Dec-25-2022)
    13,797
    Market Cap (Dec-25-2022)
    0.404 Billion USD
    World Rank (Jan-07-2022)
    5,673
    Market Cap (Jan-07-2022)
    2.34 Billion USD
    Annual Revenue in USD
    55 Million USD
    Annual Operating Income in USD
    -140 Million USD
    Annual Net Income in USD
    -164 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Nektar Therapeutics is a research based development stage Biopharmaceutical company. It R&D pipeline of new investigational drugs includes treatments for cancer and auto immune disease and leverage Nektar's proprietary and proven chemistry platform in the discovery and design of new drug candidates. The headquarters is in USA.
  5. Pharvaris N.V.

    World Rank (Aug-2026)
    5,661
    Market Cap (Aug-2026)
    2.448 Billion USD
    World Rank (Jan-05-2024)
    7,301
    Market Cap (Jan-05-2024)
    1.326 Billion USD
    World Rank (Jul-30-2023)
    11,900
    Market Cap (Jul-30-2023)
    0.573 Billion USD
    World Rank (Dec-25-2022)
    15,021
    Market Cap (Dec-25-2022)
    0.335 Billion USD
    World Rank (Jan-07-2022)
    11,928
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Headquarters Country
    Company Profile
    Pharvaris is a biotechnology sector company related clinical-stage company focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Headquarters is in Netherlands.
  6. Clover Health Investments Corp.

    World Rank (Aug-2026)
    5,665
    Market Cap (Aug-2026)
    2.443 Billion USD
    World Rank (Jan-05-2024)
    13,243
    Market Cap (Jan-05-2024)
    0.450 Billion USD
    World Rank (Jul-30-2023)
    12,458
    Market Cap (Jul-30-2023)
    0.524 Billion USD
    World Rank (Dec-25-2022)
    12,890
    Market Cap (Dec-25-2022)
    0.465 Billion USD
    World Rank (Jan-07-2022)
    7,414
    Market Cap (Jan-07-2022)
    1.50 Billion USD
    Annual Revenue in USD
    1,924 Million USD
    Annual Operating Income in USD
    -86 Million USD
    Annual Net Income in USD
    -86 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Clover Health Investments Corp is a Healthcare Technology and Insurance company. The headquarters is in USA.
  7. Bausch Health Companies

    World Rank (Aug-2026)
    5,673
    Market Cap (Aug-2026)
    2.435 Billion USD
    World Rank (Jan-05-2024)
    4,383
    Market Cap (Jan-05-2024)
    2.995 Billion USD
    World Rank (Jul-30-2023)
    3,918
    Market Cap (Jul-30-2023)
    3.484 Billion USD
    World Rank (Dec-25-2022)
    4,972
    Market Cap (Dec-25-2022)
    2.291 Billion USD
    World Rank (Jan-07-2022)
    1,934
    Market Cap (Jan-07-2022)
    9.71 Billion USD
    Annual Revenue in USD
    8,434 Million USD
    Annual Net Income in USD
    -948 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Bausch Health Companies is a pharmaceutical company. It engages in the development, manufacture, market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over the counter products. The headquarters is in Canada.

  8. Prestige Consumer Healthcare

    World Rank (Aug-2026)
    5,675
    Market Cap (Aug-2026)
    2.434 Billion USD
    World Rank (Jan-05-2024)
    4,362
    Market Cap (Jan-05-2024)
    3.012 Billion USD
    World Rank (Jul-30-2023)
    4,138
    Market Cap (Jul-30-2023)
    3.219 Billion USD
    World Rank (Dec-25-2022)
    4,012
    Market Cap (Dec-25-2022)
    3.072 Billion USD
    World Rank (Jan-07-2022)
    4,829
    Market Cap (Jan-07-2022)
    3.02 Billion USD
    Annual Revenue in USD
    1,089 Million USD
    Annual Operating Income in USD
    309 Million USD
    Annual Net Income in USD
    190 Million USD
    Annual Results for Period Ending
    For year ending March-2026
    Headquarters Country
    Company Profile

    Prestige Consumer Healthcare Manufactures and Distributes Quality in the over-the-counter Health Care and Household Cleaning Products to Retail Stores company. The company brands are digestive care, eye, ear, nose and throat, oral care, pain relief, pediatric care, skin care, sleep aids and women's health. The headquarters is in USA.

  9. Amylyx Pharmaceuticals Inc.

    World Rank (Aug-2026)
    5,709
    Market Cap (Aug-2026)
    2.410 Billion USD
    World Rank (Jan-05-2024)
    8,008
    Market Cap (Jan-05-2024)
    1.123 Billion USD
    World Rank (Jul-30-2023)
    6,840
    Market Cap (Jul-30-2023)
    1.514 Billion USD
    World Rank (Dec-25-2022)
    4,858
    Market Cap (Dec-25-2022)
    2.356 Billion USD
    World Rank (Jan-07-2022)
    8,733
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -153 Million USD
    Annual Net Income in USD
    -145 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Amylyx Pharmaceuticals Inc is a pharmaceutical company that is dedicated to the development of potential therapies for neurodegenerative diseases. The headquarters is in United States.
  10. Urogen Pharma

    World Rank (Aug-2026)
    5,781
    Market Cap (Aug-2026)
    2.357 Billion USD
    World Rank (Jan-05-2024)
    13,467
    Market Cap (Jan-05-2024)
    0.435 Billion USD
    World Rank (Jul-30-2023)
    12,378
    Market Cap (Jul-30-2023)
    0.530 Billion USD
    World Rank (Dec-25-2022)
    18,356
    Market Cap (Dec-25-2022)
    0.188 Billion USD
    World Rank (Jan-07-2022)
    18,931
    Market Cap (Jan-07-2022)
    0.20 Billion USD
    Annual Revenue in USD
    110 Million USD
    Annual Operating Income in USD
    -125 Million USD
    Annual Net Income in USD
    -153 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    UroGen Pharma is a Biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases. The company annual revenue is 3.5 million USD and 156 employees as on 2020. The headquarters is in USA.

Share

Ads